Cellectis (CLLS) Deferred Taxes (2023 - 2026)
Cellectis' (CLLS) quarterly Deferred Taxes came in at -$1.7 million in Q1 2026, up 49.6% year-on-year from -$1.1 million in Q1 2025, and up 91.04% quarter-over-quarter from -$18.9 million in Q3 2025.
Cellectis (CLLS) Deferred Taxes (2023 - 2026) Analysis & Trends
Cellectis' Deferred Taxes history runs 4 years deep, the most recent figure standing at -$1.7 million for Q1 2026.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Deferred Taxes (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | - |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | -188,883.60 |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | -65.30 Mn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 96.00 Mn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | Cellectis | 281.48 Mn | 95.81 Mn | - | -1.70 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -1.70 Mn |
| Sep 30, 2025 | -18.92 Mn |
| Jun 30, 2025 | -8.90 Mn |
| Mar 31, 2025 | -3.36 Mn |
| Sep 30, 2024 | -1.98 Mn |
| Jun 30, 2024 | -3.92 Mn |
| Mar 31, 2024 | 12.67 Mn |
| Sep 30, 2023 | -121,000.00 |
| Jun 30, 2023 | -98,000.00 |
| Mar 31, 2023 | 278,000.00 |